Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-03

FDA Approved: FOSAPREPITANT — Original Application (Avenacy, LLC)

View source ↗

Summary

FDA approved the original application for Fosaprepitant (fosaprepitant dimeglumine) by Avenacy, LLC, a generic antiemetic indicated to prevent chemotherapy-indu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)